These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16428160)

  • 1. Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent.
    Callen JP; Jackson JH
    J Dermatolog Treat; 2005; 16(5-6):350-2. PubMed ID: 16428160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recalcitrant pustular psoriasis successfully treated with adalimumab.
    Alvarez AC; Rodríguez-Nevado I; De Argila D; Rubio FP; Rovira I; Torrelo A; Zambrano A
    Pediatr Dermatol; 2011; 28(2):195-7. PubMed ID: 21504452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series.
    Bhutani T; Koo J
    J Dermatolog Treat; 2011 Apr; 22(2):75-8. PubMed ID: 20524874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ustekinumab: effective in a patient with severe recalcitrant generalized pustular psoriasis.
    Daudén E; Santiago-et-Sánchez-Mateos D; Sotomayor-López E; García-Díez A
    Br J Dermatol; 2010 Dec; 163(6):1346-7. PubMed ID: 20716216
    [No Abstract]   [Full Text] [Related]  

  • 5. Adalimumab: safe and successful in severe pustular psoriasis.
    Jordan J; Bieber T; Wilsmann-Theis D
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):592-3. PubMed ID: 18761550
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term efficacy of adalimumab in generalized pustular psoriasis.
    Zangrilli A; Papoutsaki M; Talamonti M; Chimenti S
    J Dermatolog Treat; 2008; 19(3):185-7. PubMed ID: 18569276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
    Van Lümig PP; Lecluse LL; Driessen RJ; Spuls PI; Boezeman JB; van de Kerkhof PC; De Jong EM
    Br J Dermatol; 2010 Oct; 163(4):838-46. PubMed ID: 20649798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
    Yawalkar N; Hunger RE
    Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
    [No Abstract]   [Full Text] [Related]  

  • 9. Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation.
    Martyn-Simmons CL; Green L; Ash G; Groves RW; Smith CH; Barker JN
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1394-7. PubMed ID: 19573024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pustular psoriasis development after initial ustekinumab administration in chronic plaque psoriasis.
    Gregoriou S; Kazakos C; Christofidou E; Kontochristopoulos G; Vakis G; Rigopoulos D
    Eur J Dermatol; 2011; 21(1):104-5. PubMed ID: 21233062
    [No Abstract]   [Full Text] [Related]  

  • 12. Adalimumab in the management of palmoplantar psoriasis.
    Ghate JV; Alspaugh CD
    J Drugs Dermatol; 2009 Dec; 8(12):1136-9. PubMed ID: 20027943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood generalized pustular psoriasis: successful treatment with isotretinoin.
    Al-Shobaili H; Al-Khenaizan S
    Pediatr Dermatol; 2007; 24(5):563-4. PubMed ID: 17958816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic therapy in erythrodermic and pustular psoriasis.
    Levin EC; Debbaneh M; Koo J; Liao W
    J Drugs Dermatol; 2014 Mar; 13(3):342-54. PubMed ID: 24595581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris.
    Gniadecki R; Kragballe K; Dam TN; Skov L
    Br J Dermatol; 2011 May; 164(5):1091-6. PubMed ID: 21219290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case reports: practical experience with efalizumab in hand and foot psoriasis.
    Cohen DJ; Scherschun L
    J Drugs Dermatol; 2007 Dec; 6(12):1224-30. PubMed ID: 18189064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab in the management of palmoplantar psoriasis.
    Ghate JV; Alspaugh CD
    Dermatol Online J; 2009 Jul; 15(7):15. PubMed ID: 19903443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
    Nijsten T; Spuls PI
    Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
    [No Abstract]   [Full Text] [Related]  

  • 19. Superimposed linear psoriasis unmasked by therapy with adalimumab.
    Arnold AW; Happle R; Itin PH
    Eur J Dermatol; 2010; 20(5):573-4. PubMed ID: 20621851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pustular psoriasis with infliximab.
    Weishaupt C; Metze D; Luger TA; Ständer S
    J Dtsch Dermatol Ges; 2007 May; 5(5):397-9. PubMed ID: 17451384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.